BradyLaughlinMD

Radiation Oncologist at Mayo Clinic Arizona

Dr. Laughlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Brady Laughlin, based in Scottsdale, AZ, is a specialist in Radiation Oncology. He received his medical degree from University of Arizona College of Medicine in 2019 and completed a residency in Radiation Oncology at Mayo Clinic College of Medicine and Science (Phoenix) from 2019 to 2024. Dr. Laughlin is currently employed as a Radiation Oncologist at Mayo Clinic Hospital. He has several publications in notable medical journals relating to the field of radiation oncology, including Neuro-Oncology Practice and Journal of Applied Clinical Medical Physics. He has been honored by being a member of the Alpha Omega Alpha Honor Medical Society since 2017.

Mayo Clinic College of Medicine and Science (Phoenix)Residency, Radiation Oncology, 2019 - 2024
University of Arizona College of MedicineClass of 2019

PubMed

Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial.
Diego A S Toesca, William F Hartsell, Todd A DeWees, John H Chang, Brady S Laughlin
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01
1 citations
Comprehensive clinical implementation, workflow, and FMEA of bespoke silicone bolus cast from 3D printed molds using open-source resources.
Dean Hobbis, Michael D Armstrong, Samir H Patel, Riley C Tegtmeier, Brady S Laughlin
Journal of Applied Clinical Medical Physics. 2024-11-01
Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging.
Jingwei Duan, Riley C Tegtmeier, Carlos E Vargas, Nathan Y Yu, Brady S Laughlin
Radiotherapy and Oncology. 2024-10-16

Journal Articles

Physician and Patient-Reported Outcomes of the MC1635 Phase III Trial of Ultra-Hypofractionated Versus Moderate Hypofractionated Adjuvant Radiotherapy After Breast-Con...
Brady S. Laughlin MD , Kimberly A. Corbin MD , Diego Augusto Santos Toesca MD , Cameron S. Thorpe MD , Michael A. Golafshar MS , Barbara Pockaj MD , Patricia Cronin MD..., International Journal of Radiation Oncology, Biology, Physics, 10/30/2023

Lectures

Clinical outcome associated with neoadjuvant chemoradiation and orthotopic liver transplantation versus definitive chemoradiation in 49 patients with unresectable, hil...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020